MRI of neurologic complications in end-stage renal failure patients on hemodialysis: Pictorial review

被引：0

作者：

Muhteşem Aǧildere A. ^{[1
]}

Kurt A. ^{[1
]}

Yildirim T. ^{[1
]}

Benli S. ^{[1
]}

Altinörs N. ^{[1
]}

机构：

[1] Department of Radiology, Baskent Univ. Faculty of Medicine, 06490 Bahçelievler Ankara

来源：

European Radiology | 2001年 / 11卷 / 6期

关键词：

Central nervous system; End-stage renal failure; Hemodialysis; MRI;

D O I：

10.1007/s003300000688

中图分类号：

学科分类号：

摘要：

End-stage renal disease patients who have been on long-term hemodialysis tend to develop central nervous system complications. The most common neurologic complications in this patient group include white matter changes, cerebral atrophy, osmotic demyelination syndrome, dialysis encephalopathy, hypertensive encephalopathy, intracranial hemorrhage, infarct, sinus thrombosis, and infection. Clinical evaluation of these patients is somehow complicated and MRI is important before establishment of the therapy. The purpose of this article is to illustrate the range of MRI findings of neurologic complications in end-stage renal failure patients on hemodialysis with etiologic factors.

引用

页码：1063 / 1069

页数：6

共 17 条

[1]

Raskin N.H., Neurological complications of renal failure, Neurology and General Medicine, pp. 311-313, (1995)

[2]

Burn D.J., Bates D., Neurology and kidney, J Neural Neurosurg Psychiatry, 65, pp. 810-821, (1998)

[3]

Savazzi G.M., Pathogenesis of cerebral atrophy in uraemia, Nephron, 49, pp. 94-103, (1988)

[4]

Savazzi G.M., Cusmano F., Bergamaschi E., Vinci S., Allegri L., Garini G., Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients, Nephron, 81, pp. 17-24, (1999)

[5]

Papageorgiou C., Ziroyannis P., Vathylakis J., Grigerladis A., Hatzikonstantinou V., Capsakalis Z., A comparative study of brain atrophy by computerized tomography in chronic renal failure and chronic hemodialysis, Acta Neurol Scand, 66, pp. 378-385, (1982)

[6]

Agildere M., Benli S., Erten Y., Coskun M., Boyvat F., Ozdemir N., Osmotic demyelination syndrome with a disequilibrium syndrome: Reversible MRI findings, Neuroradiology, 40, pp. 228-232, (1998)

[7]

Cohen G., Haag-Weber M., Horl W.H., Immune dysfunction in uremia, Kidney Int Suppl, 62, pp. 79-82, (1997)

[8]

Endo Y., Oda M., Hara M., Central pontine myelinolysis, Acta Neuropathol, 53, pp. 145-153, (1981)

[9]

Weigert A.L., Schafer A.I., Uremic bleeding: Pathogenesis and therapy, Am J Med Sci, 316, pp. 94-104, (1998)

[10]

Geissler A., Frund R., Kohler S., Eichhorn H.M., Kramer K.B., Feuerbach S., Cerebral metabolite patterns in dialysis patients: Evaluation with H-1 MR spectroscopy, Radiology, 194, pp. 693-697, (1995)

← 1 2 →